Abstract
An ideal replacement for bone defects is auto-bone tissue, of which there is an ample supply with the required form and with vascularity. Our strategy for generating such bone tissue is as follows. First, bone tissue is induced in muscle by bone morphogenetic protein-2 (BMP-2) with beta-tricalcium phosphate as a carrier to maintain its form in the muscle. Second, the induced bone in the muscle pedicle is grafted to the bone defect to maintain vascularity. In the first experiment, 50μg of recombinant human BMP-2 (rhBMP-2) was inoculated into the hip abductor muscle of rabbits with beta-tricalcium phosphate under anesthesia. Five weeks after the operation, intramuscular bone formation was observed in all of the samples, and the form and size of the induced bone tissue were identical to those of the carrier. Ten weeks after the operation, the induced bone was partly absorbed. In the second experiment, 50μg of rhBMP-2 was inoculated in the same manner as previously. Five weeks after the operation, the muscle tissue around the induced bone was incised, leaving just the proximal part as a pedicle. Two or four weeks after the second operation, the induced bone tissue had rich vascularity and no empty lacunae. This indicates the possibility of in vivo bone banking to enable morphologically controlled and vascularized auto-bone grafts.
| Original language | English |
|---|---|
| Pages (from-to) | 490-494 |
| Number of pages | 5 |
| Journal | Journal of Orthopaedic Science |
| Volume | 7 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Jan 1 2002 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Surgery
- Orthopedics and Sports Medicine
Cite this
Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier : In vivo bone banking for muscle-pedicle autograft. / Jingushi, Seiya; Urabe, Ken; Okazaki, Ken; Hirata, Go; Sakai, Akihiro; Ikenoue, Takashi; Iwamoto, Yukihide.
In: Journal of Orthopaedic Science, Vol. 7, No. 4, 01.01.2002, p. 490-494.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier
T2 - In vivo bone banking for muscle-pedicle autograft
AU - Jingushi, Seiya
AU - Urabe, Ken
AU - Okazaki, Ken
AU - Hirata, Go
AU - Sakai, Akihiro
AU - Ikenoue, Takashi
AU - Iwamoto, Yukihide
PY - 2002/1/1
Y1 - 2002/1/1
N2 - An ideal replacement for bone defects is auto-bone tissue, of which there is an ample supply with the required form and with vascularity. Our strategy for generating such bone tissue is as follows. First, bone tissue is induced in muscle by bone morphogenetic protein-2 (BMP-2) with beta-tricalcium phosphate as a carrier to maintain its form in the muscle. Second, the induced bone in the muscle pedicle is grafted to the bone defect to maintain vascularity. In the first experiment, 50μg of recombinant human BMP-2 (rhBMP-2) was inoculated into the hip abductor muscle of rabbits with beta-tricalcium phosphate under anesthesia. Five weeks after the operation, intramuscular bone formation was observed in all of the samples, and the form and size of the induced bone tissue were identical to those of the carrier. Ten weeks after the operation, the induced bone was partly absorbed. In the second experiment, 50μg of rhBMP-2 was inoculated in the same manner as previously. Five weeks after the operation, the muscle tissue around the induced bone was incised, leaving just the proximal part as a pedicle. Two or four weeks after the second operation, the induced bone tissue had rich vascularity and no empty lacunae. This indicates the possibility of in vivo bone banking to enable morphologically controlled and vascularized auto-bone grafts.
AB - An ideal replacement for bone defects is auto-bone tissue, of which there is an ample supply with the required form and with vascularity. Our strategy for generating such bone tissue is as follows. First, bone tissue is induced in muscle by bone morphogenetic protein-2 (BMP-2) with beta-tricalcium phosphate as a carrier to maintain its form in the muscle. Second, the induced bone in the muscle pedicle is grafted to the bone defect to maintain vascularity. In the first experiment, 50μg of recombinant human BMP-2 (rhBMP-2) was inoculated into the hip abductor muscle of rabbits with beta-tricalcium phosphate under anesthesia. Five weeks after the operation, intramuscular bone formation was observed in all of the samples, and the form and size of the induced bone tissue were identical to those of the carrier. Ten weeks after the operation, the induced bone was partly absorbed. In the second experiment, 50μg of rhBMP-2 was inoculated in the same manner as previously. Five weeks after the operation, the muscle tissue around the induced bone was incised, leaving just the proximal part as a pedicle. Two or four weeks after the second operation, the induced bone tissue had rich vascularity and no empty lacunae. This indicates the possibility of in vivo bone banking to enable morphologically controlled and vascularized auto-bone grafts.
UR - http://www.scopus.com/inward/record.url?scp=0036024603&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036024603&partnerID=8YFLogxK
U2 - 10.1007/s007760200085
DO - 10.1007/s007760200085
M3 - Article
C2 - 12181665
AN - SCOPUS:0036024603
VL - 7
SP - 490
EP - 494
JO - Journal of Orthopaedic Science
JF - Journal of Orthopaedic Science
SN - 0949-2658
IS - 4
ER -